Pharma cos targetting niche products to stay fit
Indian pharma companies are increasingly relying on positioning themselves in niche or specialty areas to increase their revenues. Diabetes patients saw a revolution in insulin drugs last year, when Shreya Life Sciences launched the world’s first oral insulin under the brand name of 'Oral- Recosulin'. The company’s top brass already announced that it is bullish on specialty products.
![[Partner Content] Why You Should Upgrade to OPPO Reno12 5G](https://c.ndtvimg.com/2024-07/qi8tnmhk_oppo_640x480_24_July_24.jpg?downsize=355∶533 "[Partner Content] Why You Should Upgrade to OPPO Reno12 5G")
